Brief: Avidity Partners Management Reports 9.4% Passive Stake In Phasebio Pharmaceuticals
22/03/2021 21:43
March 22 (Reuters) - Avidity Partners Management:
* AVIDITY PARTNERS MANAGEMENT LP REPORTS 9.4% PASSIVE STAKE
IN
PHASEBIO PHARMACEUTICALS INC AS OF MARCH 18 - SEC FILING
Source: (https://bit.ly/31azaLw)
Further company coverage: PHAS.O
((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))
Recent news on PhaseBio Pharmaceuticals
See all newsBrief: Phasebio Pharmaceuticals Says Bankruptcy Court Entered Order Approving 1st Amended Combined Disclosure Statement & Chapter 11 Plan On Final Basis
U.S. RESEARCH ROUNDUP- Entegris, FedEx, Kellogg
U.S. RESEARCH ROUNDUP- Armstrong World Industries, Eli Lilly, Netflix
U.S. STOCKS ON THE MOVE-TransDigm, Vaxcyte, Tricida
PhaseBio Pharma slips on bankruptcy plans